What triggered the 1643.HK stock drop pre-market?

The pre-market decline was driven by heavy selling and a volume spike to 16,026,000 shares. No public earnings release accompanied the move, so price action appears sentiment and liquidity driven rather than a single announcement.

What is Meyka AI's current grade for 1643.HK stock?

Meyka AI assigns 1643.HK a score of 63.60 out of 100, Grade B with a HOLD suggestion. The grade blends benchmark, sector, financials, metrics, and analyst data and is informational only.

Does Meyka AI forecast upside or downside for 1643.HK stock?

Meyka AI's model projects **HK$1.05** in 12 months, implying **-17.04%** from **HK$1.26**, and **HK$1.74** in three years, implying **+37.81%**. These are model projections, not guarantees.

Which metrics should investors watch for 1643.HK stock?

Key metrics are EPS **HK$0.04**, PE **31.50**, price-to-book **1.82**, cash per share **HK$0.47**, and operating cash flow per share at **-HK$0.01**. Monitor liquidity and any regulatory or product news.

HK Stocks

Pre-market: 1643.HK Modern Chinese Medicine (HKSE) -24.55% HK$1.26: forecasts

ByHuzaifa Zahoor March 11, 2026

The 1643.HK stock plunged in pre-market trade, sliding 24.55% to HK$1.26 on heavy volume. Today’s move follows a gap lower from an open at HK$1.68, with intraday range HK$1.25–HK$2.00. Volume spiked to 16,026,000 shares, nearly ten times the average, signalling aggressive selling pressure ahead of Hong Kong trade.